BioCentury
ARTICLE | Company News

Hemagen deal

December 20, 1993 8:00 AM UTC

HMGN entered into a renewable five-year agreement with Boehringer Mannheim GmbH to develop immunoassays using proprietary technology from both companies. The first test to be developed is an assay for...